In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Aligos Therapeutics Inc (NASDAQ: ALGS) closed at $19.58 in the last session, up 9.69% from day before closing price of $17.85. In other words, the price has increased by $9.69 from its previous closing price. On the day, 1.22 million shares were traded. ALGS stock price reached its highest trading level at $21.88 during the session, while it also had its lowest trading level at $18.2.
Ratios:
We take a closer look at ALGS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 3.81. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 19, 2024, initiated with a Buy rating and assigned the stock a target price of $75.
On January 06, 2023, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $2 to $3.
Jefferies Upgraded its Hold to Buy on January 06, 2023, whereas the target price for the stock was revised from $2.50 to $3.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALGS now has a Market Capitalization of 67829032 and an Enterprise Value of -27058616. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.71 while its Price-to-Book (P/B) ratio in mrq is 1.30. Its current Enterprise Value per Revenue stands at -3.396 whereas that against EBITDA is 0.296.
Stock Price History:
Over the past 52 weeks, ALGS has reached a high of $30.00, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is 93.72%, while the 200-Day Moving Average is calculated to be 28.08%.
Shares Statistics:
According to the various share statistics, ALGS traded on average about 168.82K shares per day over the past 3-months and 571100 shares per day over the past 10 days. A total of 2.88M shares are outstanding, with a floating share count of 2.54M. Insiders hold about 29.21% of the company’s shares, while institutions hold 53.80% stake in the company. Shares short for ALGS as of 1728950400 were 82817 with a Short Ratio of 0.72, compared to 1726185600 on 34726. Therefore, it implies a Short% of Shares Outstanding of 82817 and a Short% of Float of 4.46.
